Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase NA 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1

Interventions

Exercise 83Standard of Care 45Blood Specimen Collection 43Methods 32Therapeutics 28Surveys and Questionnaires 27Educational Status 25Control Groups 20Cognitive Behavioral Therapy 20Interviews as Topic 18Music Therapy 15Biopsy 15Acupuncture Therapy 15Palliative Care 14Resistance Training 13Magnetic Resonance Spectroscopy 13Early Intervention, Educational 13Radiotherapy 10Radiosurgery 10Nutrition Assessment 9Behavior Therapy 9Yoga 8Psychiatric Rehabilitation 8Practice Guidelines as Topic 8Patient Navigation 8Counseling 8Ultraviolet Therapy 7Physical Therapy Modalities 7Nutritional Status 7Mindfulness 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasms × vandetanib × Clear all
NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Amsterdam UMC, location VUmc

Phase NA Unknown
15 enrolled
CNS

Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡